Breaking News Instant updates and real-time market news.

2022-01-25 13:45:00 13:45 01/25/22 01/25 13:45 01/25/22 13:45	Goldman Sachs alternative energy analysts hold analyst/industry conference call Alternative Energy & Services Analysts, along with Chris Collins, Founder of Ohm Analytics, provide a quarterly residential solar update on an Analyst/Industry conference call to be held on January 25 at 2 pm. Webcast Link

2022-01-25 13:45:00

13:45

01/25/22

01/25

13:45

01/25/22

13:45

Goldman Sachs alternative energy analysts hold analyst/industry conference call

Alternative Energy & Services Analysts, along with Chris Collins, Founder of Ohm Analytics, provide a quarterly residential solar update on an Analyst/Industry conference call to be held on January 25 at 2 pm. Webcast Link

OTHER BREAKING NEWS FROM THE FLY

Upgrade	CubeSmart upgraded to Strong Buy from Outperform at Raymond James » 06:52 05/23/22 05/23 06:52 05/23/22 06:52 CUBE CubeSmart $40.85 / +0.14 (+0.34%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate CUBE CubeSmart $40.85 / +0.14 (+0.34%) 04:47 Today Raymond James CubeSmart upgraded to Strong Buy from Outperform at Raymond James 05/16/22 Truist CubeSmart price target lowered to $48 from $55 at Truist 04/04/22 JPMorgan CubeSmart price target raised to $58 from $57 at JPMorgan 01/24/22 Stifel CubeSmart called 'favorite storage name' at Stifel after management meeting CUBE CubeSmart $40.85 / +0.14 (+0.34%) 04/28/22 CubeSmart reports Q1 AFFO 58c, consensus 57c 04/28/22 CubeSmart raises FY22 AFFO view $2.37-$2.42 from $2.35-$2.42, consensus $2.46 02/24/22 CubeSmart sees FY22 adjusted FFO/share $2.35-$2.42, consensus $2.41 02/24/22 CubeSmart reports Q4 adjusted FFO/share 58c, consensus 56c 17 Nov
Hot Stocks	Spire Global awarded TCOM subcontract for weather forecasts at aerostat sites » 06:52 05/23/22 05/23 06:52 05/23/22 06:52 SPIR Spire Global $1.44 / -0.03 (-2.04%) Spire Global was awarded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SPIR Spire Global $1.44 / -0.03 (-2.04%) 03/24/22 Spire Global expands relationship with Slingshot Aerospace 03/16/22 Spire Global announces space-as-a-service agreement with NorthStar Earth & Space 03/07/22 Spire Global, Sierra Nevada announce strategic partnership 02/11/22 Spire Global trading resumes SPIR Spire Global $1.44 / -0.03 (-2.04%) 04/21/22 Raymond James Spire Global initiated with an Outperform at Raymond James 03/28/22 CJS Securities Spire Global initiated with an Outperform at CJS Securities 03/03/22 Stifel Spire Global initiated with a Buy at Stifel 01/19/22 BofA Spire Global downgraded to Underperform at BofA on valuation SPIR Spire Global $1.44 / -0.03 (-2.04%) 05/11/22 Spire Global raises FY22 EPS view to (43c)-(39c) from (44c)-(41c) 05/11/22 Spire Global sees Q2 adjusted EPS (12c)-(11c), consensus (12c) 05/11/22 Spire Global reports Q1 EPS (13c), consensus (13c) 03/09/22 Spire Global sees FY22 adjusted EPS (44c)-(41c), consensus (39c) SPIR Spire Global $1.44 / -0.03 (-2.04%) 04/22/22 What You Missed On Wall Street On Friday 04/22/22 What You Missed On Wall Street This Morning 04/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/03/22 What You Missed On Wall Street On Thursday 06/01/22 Spire Global Inc SPIR Spire Global $1.44 / -0.03 (-2.04%) 03/09/22 Spire Global options imply 31.3% move in share price post-earnings 02/07/22 Largest borrow rate increases among liquid names 12/14/21 Largest borrow rate increases among liquid names
Downgrade	Axon assumed at Equal Weight from Overweight at Morgan Stanley » 06:50 05/23/22 05/23 06:50 05/23/22 06:50 AXON Axon $99.50 / +1 (+1.02%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AXON Axon $99.50 / +1 (+1.02%) 05/19/22 Axon, Fusus partner to provide real-time community policing solutions 05/04/22 Axon names Jim Zito as interim CFO, succeeding Jawad Ahsan 04/18/22 Axon signs five-year contract with Columbus Division of Police 04/06/22 Axon acquires virtual reality training studio 'Foundry 45,' terms not disclosed AXON Axon $99.50 / +1 (+1.02%) 06:42 Today Morgan Stanley Axon downgraded to Equal Weight from Overweight at Morgan Stanley 05/16/22 Baird Baird downgrades three cloud stocks on focus shift to cash flows 05/12/22 Northland Axon price target lowered to $130 from $180 at Northland 05/11/22 Baird Axon price target lowered to $125 from $145 at Baird AXON Axon $99.50 / +1 (+1.02%) 05/10/22 Axon raises FY22 revenue view to $1.05B-$1.1B from $1.04B, consensus $1.05B 05/10/22 Axon reports Q1 adjusted EPS 45c, consensus 30c 05/04/22 Axon raises FY22 revenue view to $1.05B-$1.1B from $1.04B 02/24/22 Axon sees FY22 revenue $1.04B, consensus $1.01B AXON Axon $99.50 / +1 (+1.02%) 05/10/22 Fly Intel: After-Hours Movers 06/22/22 Axon
Initiation	Regeneron initiated with an Outperform at SVB Leerink » 06:50 05/23/22 05/23 06:50 05/23/22 06:50 REGN Regeneron $661.76 / +3.73 (+0.57%) SVB Leerink analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events REGN Regeneron $661.76 / +3.73 (+0.57%) 05/22/22 Regeneron announces results from Phase 3 trial evaluating Evkeeza in HoFH 05/20/22 Regeneron, Sanofi confirm FDA approves Dupixent for EoE 05/20/22 FDA approves Regeneron's Dupixent to treat eosinophilic esophagitis 05/04/22 Regeneron sees FY22 gross margin on net product sales 90%-92% REGN Regeneron $661.76 / +3.73 (+0.57%) 05/13/22 Piper Sandler Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler 04/20/22 Cowen Regeneron price target raised to $645 from $640 at Cowen 04/20/22 BTIG Checkmate Pharmaceuticals downgraded to Neutral from Buy at BTIG 04/19/22 Baird Decibel could be next target for Regeneron, says Baird REGN Regeneron $661.76 / +3.73 (+0.57%) 05/04/22 Regeneron reports Q1 EPS $11.49, consensus $9.89 02/04/22 Regeneron reports Q4 EPS $23.72, consensus $18.02 02/03/22 Notable companies reporting before tomorrow's open 02/03/22 Notable companies reporting before tomorrow's open REGN Regeneron $661.76 / +3.73 (+0.57%) 01/25/22 White House limits use of Regeneron, Lilly Covid-19 antibody drugs, WSJ reports 12/22/21 Most monoclonal antibody treatments failing against omicron, NY Times reports 12/03/21 FDA planning fast review of omicron vaccines and drugs, WSJ reports 11/30/21 COVID-19 antibody drugs struggle with omnicron, WSJ reports REGN Regeneron $661.76 / +3.73 (+0.57%) 04/19/22 What You Missed On Wall Street On Tuesday 04/19/22 What You Missed On Wall Street This Morning 04/19/22 Street expert sees over 800% upside for this potential biotech M&A target 12/23/21 Wall Street in Fives - Must Read Lists for Thursday 09/07/22 2022 Wells Fargo Healthcare Conference 06/09/22 PDUFA Date for Dupixent 07/13/22 Extended PDUFA Date for REGEN-COV 08/03/22 PDUFA Date for Dupixent 09/19/22 PDUFA Date for Libtayo 06/10/22 Regeneron Pharmaceuticals
Hot Stocks	Cable One authorizes additional share repurchase of up to $450M » 06:49 05/23/22 05/23 06:49 05/23/22 06:49 CABO Cable One $1,193.94 / +17.89 (+1.52%) Cable One has authorized… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CABO Cable One $1,193.94 / +17.89 (+1.52%) 04/12/22 Cable One announces CFO transition plan CABO Cable One $1,193.94 / +17.89 (+1.52%) 05/06/22 Truist Cable One price target lowered to $1,400 from $2,000 at Truist 05/06/22 KeyBanc Cable One price target lowered to $1,896 from $2,326 at KeyBanc 05/06/22 Wells Fargo Cable One price target lowered to $1,800 from $2,100 at Wells Fargo 04/13/22 Wells Fargo Wells Fargo expects 'smooth' CFO transition, remains bullish on Cable One CABO Cable One $1,193.94 / +17.89 (+1.52%) 05/05/22 Cable One reports Q1 EPS $26.85, consensus $11.48 02/24/22 Cable One reports Q4 EPS $10.54, consensus $11.79 06/13/22 2022 Wells Fargo Streaming & Connectivity Conference

Initiation	Sanofi initiated with an Outperform at SVB Leerink » 06:48 05/23/22 05/23 06:48 05/23/22 06:48 SNY Sanofi $54.38 / +1.3 (+2.45%) SVB Leerink analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly SNY Sanofi $54.38 / +1.3 (+2.45%) 05/20/22 Regeneron, Sanofi confirm FDA approves Dupixent for EoE 05/20/22 Kymera presents preclinical data on IRAK4 degrader KT-474 at SID meeting 05/10/22 Rallybio announces in-licensing of Sanofi's KY1066 05/06/22 IGM Biosciences announces closing of global collaboration agreement with Sanofi SNY Sanofi $54.38 / +1.3 (+2.45%) 05/09/22 Wedbush Wedbush downgrades Arvinas to Neutral, cuts price target to $43 05/02/22 Guggenheim Sanofi price target raised to EUR 127 from EUR 121 at Guggenheim 04/28/22 Credit Suisse Kymera Therapeutics initiated with an Outperform at Credit Suisse 04/26/22 Stifel Arvinas price target lowered to $85 from $93 at Stifel SNY Sanofi $54.38 / +1.3 (+2.45%) 04/28/22 Sanofi still expects 2022 business EPS to grow low double-digit at CER 04/28/22 Sanofi reports Q1 business EPS EUR 1.94, up 16.1% at CER 02/04/22 Sanofi sees 2022 business EPS to grow low double-digit at CER 02/04/22 Sanofi reports Q4 business EPS EUR 1.38, up 9.8% at CER SNY Sanofi $54.38 / +1.3 (+2.45%) 01/29/22 Moderna faces challenges beyond COVID vaccine, stock still a buy, Barron's says 01/05/22 French court permits class action against Sanofi over Depakine, Reuters says 12/29/21 Viatris wins appeal ruling over Sanofi related to Lantus patents, Bloomberg says 12/15/21 Sanofi's Covid vaccine release now expected in 1Q22, FT reports SNY Sanofi $54.38 / +1.3 (+2.45%) 04/02/22 Short Report: IGM Biosciences deal with Sanofi send shorts to exits 03/29/22 What You Missed On Wall Street On Tuesday 03/29/22 What You Missed On Wall Street This Morning 01/05/22 Wall Street in Fives - Must Read Lists for Wednesday
Hot Stocks	Ocwen authorizes $50M share repurchase program » 06:47 05/23/22 05/23 06:47 05/23/22 06:47 OCN Ocwen $23.08 / -0.59 (-2.49%) Ocwen authorized a share… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options OCN Ocwen $23.08 / -0.59 (-2.49%) 05/18/22 Ocwen appoints Sean O'Neil CFO 04/28/22 Ocwen rises 19.3% 04/08/22 Ocwen issues statement on U.S. Court of Appeals decision in CFPB matter 02/14/22 Cooperman's Omega added Mirion, Discovery and Gan in Q4 OCN Ocwen $23.08 / -0.59 (-2.49%) 04/20/22 BTIG Ocwen initiated with a Neutral at BTIG 03/16/22 B. Riley Ocwen price target lowered to $50 from $56 at B. Riley 12/08/21 B. Riley Ocwen price target raised to $56 from $50 at B. Riley 09/09/21 B. Riley B. Riley starts Ocwen with Buy, sees turnaround story in 'early innings' OCN Ocwen $23.08 / -0.59 (-2.49%) 05/05/22 Ocwen reports Q1 EPS $6.30, may not compare to consensus 75c 05/25/22 Ocwen Financial Corp OCN Ocwen $23.08 / -0.59 (-2.49%) 02/25/22 Ocwen Financial options imply 2.7% move in share price post-earnings
Hot Stocks	Pfizer, BioNTech vaccine demonstrates strong immune response in Phase 2/3 trial » 06:47 05/23/22 05/23 06:47 05/23/22 06:47 PFE Pfizer $52.46 / +1.805 (+3.56%) , BNTX BioNTech $163.00 / -4.48 (-2.67%) Pfizer (PFE) and BioNTech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $52.46 / +1.805 (+3.56%) 05/17/22 Pfizer, BioNTech receive FDA emergency use authorization for child booster 05/17/22 FDA expands eligibility for Pfizer-BioNTech booster to kids 5-11 years old 05/16/22 Mirati Therapeutics appoints Laurie Stelzer as CFO 05/13/22 Pfizer EVP Carapezzi sells 32,908 common shares BNTX BioNTech $163.00 / -4.48 (-2.67%) 05/17/22 Pfizer, BioNTech receive FDA emergency use authorization for child booster 05/17/22 FDA expands eligibility for Pfizer-BioNTech booster to kids 5-11 years old 05/09/22 BioNTech backs FY22 CapEx view EUR 450M- EUR 550M 05/09/22 BioNTech backs FY22 COVID-19 vaccine revenue view EUR 13B-EUR 17B PFE BNTX PFE Pfizer $52.46 / +1.805 (+3.56%) 06:38 Today SVB Leerink Pfizer initiated with a Market Perform at SVB Leerink 05/11/22 H.C. Wainwright Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/05/22 Stifel Stifel keeps Buy rating on Arvinas, lowers price target to $82 BNTX BioNTech $163.00 / -4.48 (-2.67%) 04/12/22 H.C. Wainwright BioNTech price target lowered to $298 from $339 at H.C. Wainwright 04/11/22 H.C. Wainwright H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab 04/05/22 Canaccord BioNTech price target lowered to $300 from $450 at Canaccord 02/23/22 H.C. Wainwright BioNTech price target lowered to $336 from $366 at H.C. Wainwright PFE BNTX PFE Pfizer $52.46 / +1.805 (+3.56%) 05/03/22 Pfizer cuts FY22 adjusted EPS view to $6.25-$6.45 from $6.35-$6.55 05/03/22 Pfizer reports Q1 adjusted EPS $1.62, consensus $1.47 05/02/22 Notable companies reporting before tomorrow's open 05/02/22 Notable companies reporting before tomorrow's open BNTX BioNTech $163.00 / -4.48 (-2.67%) 05/09/22 BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year 03/30/22 BioNTech reports Q4 EPS EUR 12.18 vs. EUR 1.43 last year PFE BNTX PFE Pfizer $52.46 / +1.805 (+3.56%) 05/19/22 CDC panel backs booster dose for Pfizer COVID vaccine for kids aged 5-11 05/16/22 Pfizer, BioNTech Covid booster for kids 5-11 expected to be authorized, NYT says 05/04/22 FDA says no data support second course of Pfizer's Paxlovid, Bloomberg says 04/26/22 Biden administration to make Covid pills more widely available, WSJ reports BNTX BioNTech $163.00 / -4.48 (-2.67%) 05/19/22 CDC panel backs booster dose for Pfizer COVID vaccine for kids aged 5-11 05/16/22 Pfizer, BioNTech Covid booster for kids 5-11 expected to be authorized, NYT says 03/28/22 Biden administration plans to offer second booster shots for some, NYT reports 03/23/22 Biden administration eyes new COVID booster shot recommendation, Politico says PFE BNTX PFE Pfizer $52.46 / +1.805 (+3.56%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: Pre-market Movers 05/03/22 What You Missed On Wall Street On Tuesday BNTX BioNTech $163.00 / -4.48 (-2.67%) 04/14/22 What You Missed On Wall Street On Thursday 04/14/22 What You Missed On Wall Street This Morning 03/30/22 Fly Intel: Pre-market Movers 03/29/22 What You Missed On Wall Street On Tuesday 00:00 Today 8th Annual Berenberg Conference USA 2022 06/02/22 38th Annual Strategic Decisions Conference 06/03/22 2022 ASCO Annual Meeting 08/08/22 BioNTech - BNTX 08/06/22 Extended PDUFA Date for MYFEMBREE 05/26/22 Pfizer 06/01/22 BioNTech SE PFE BNTX PFE Pfizer $52.46 / +1.805 (+3.56%) 05/20/22 Early notable gainers among liquid option names on May 20th 04/26/22 Unusually active option classes on open April 26th 04/11/22 Unusually active option classes on open April 11th 04/07/22 Pfizer call volume above normal and directionally bullish BNTX BioNTech $163.00 / -4.48 (-2.67%) 03/30/22 Unusually active option classes on open March 30th 03/01/22 BioNTech SE put volume heavy and directionally bearish 02/08/22 BioNTech SE put volume heavy and directionally bearish 12/13/21 BioNTech SE call volume above normal and directionally bullish
Upgrade	Motorola Solutions assumed at Overweight from Equal Weight at Morgan Stanley » 06:47 05/23/22 05/23 06:47 05/23/22 06:47 MSI Motorola Solutions $210.37 / -0.035 (-0.02%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MSI Motorola Solutions $210.37 / -0.035 (-0.02%) 05/19/22 GlobalFoundries, Motorola announce strategic agreement for chip supply 05/12/22 Motorola Solutions acquires Videotec, terms not disclosed 04/19/22 Motorola Solutions acquires Calipsa, terms not disclosed 03/30/22 MetroRio deploys Motorola Solutions' body-worn cameras MSI Motorola Solutions $210.37 / -0.035 (-0.02%) 06:43 Today Morgan Stanley Motorola Solutions upgraded to Overweight from Equal Weight at Morgan Stanley 05/09/22 Credit Suisse Credit Suisse starts Axon at Outperform with $169 price target 05/09/22 Credit Suisse Credit Suisse starts Tyler Technologies at Neutral with $408 price target 04/25/22 Loop Capital Motorola Solutions initiated with a Buy at Loop Capital MSI Motorola Solutions $210.37 / -0.035 (-0.02%) 05/12/22 Motorola Solutions backs FY22 EPS view of $9.80-$9.95, consensus $9.85 05/12/22 Motorola Solutions sees Q2 EPS $1.83-$1.88, consensus $2.09 05/12/22 Motorola Solutions reports Q1 EPS $1.70, consensus $1.61 05/12/22 Notable companies reporting after market close MSI Motorola Solutions $210.37 / -0.035 (-0.02%) 05/12/22 Fly Intel: After-Hours Movers 00:00 Today 50th Annual Global Technology, Media & Communications Conference
Downgrade	Covetrus downgraded to Market Perform from Outperform at Raymond James » 06:46 05/23/22 05/23 06:46 05/23/22 06:46 CVET Covetrus $19.68 / +1.65 (+9.15%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CVET Covetrus $19.68 / +1.65 (+9.15%) 05/20/22 Covetrus jumps 15% after confirming receipt of $21 per share buyout proposal 04/04/22 PetVivo announces Schumaker joins as Business Development Manager for Midwest 12/21/21 Covetrus announces new structure within Europe CVET Covetrus $19.68 / +1.65 (+9.15%) 05/09/22 Barclays Covetrus price target lowered to $26 from $38 at Barclays 01/12/22 Goldman Sachs Covetrus' 2022 Rx revenue outlook may be disappointing, says Goldman Sachs 11/18/21 Morgan Stanley Covetrus initiated with an Equal Weight at Morgan Stanley 08/04/21 Credit Suisse Covetrus assumed with a Neutral at Credit Suisse CVET Covetrus $19.68 / +1.65 (+9.15%) 05/05/22 Covetrus backs FY22 revenue growth view 7%-8%, consensus $4.88B 05/05/22 Covetrus reports Q1 EPS (2c), consensus 22c 02/24/22 Covetrus sees FY22 organic net sales growth of 7%-8% 02/24/22 Covetrus reports Q4 GAAP EPS (2c) vs. (4c) a year ago CVET Covetrus $19.68 / +1.65 (+9.15%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 01/13/22 Wall Street in Fives - Must Read Lists for Thursday 01/13/22 Wall Street in Fives - Must Read Lists at Midday

Initiation	Vertex Pharmaceuticals initiated with a Market Perform at SVB Leerink » 06:45 05/23/22 05/23 06:45 05/23/22 06:45 VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) SVB Leerink analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) 05/18/22 Vertex Pharmaceuticals appoints Suketu Upadhyay to board of directors 05/17/22 Vertex Pharmaceuticals announces expansion plans in Boston's Seaport 05/05/22 Vertex Pharmaceuticals still sees FY22 product revenues $8.4B-$8.6B 05/02/22 Vertex Pharmaceuticals provides update on VX-880 trial VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) 05/06/22 Wells Fargo Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo 05/06/22 Baird Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance 05/06/22 Baird Vertex Pharmaceuticals downgraded to Neutral from Outperform at Baird 05/06/22 Piper Sandler Vertex Pharmaceuticals price target lowered to $242 from $249 at Piper Sandler VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) 05/05/22 Vertex Pharmaceuticals reports Q1 adjusted EPS $3.52, consensus $3.49 05/05/22 Notable companies reporting after market close 01/26/22 Vertex Pharmaceuticals reports Q4 EPS $3.37, consensus $3.29 01/26/22 Notable companies reporting after market close VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) 01/08/22 Biotech due to bounce back, Vertex stands out, Barron's says VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) 05/06/22 What You Missed On Wall Street On Friday 05/06/22 What You Missed On Wall Street This Morning 05/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/02/22 What You Missed On Wall Street On Monday VRTX Vertex Pharmaceuticals $258.71 / +3.265 (+1.28%) 01/10/22 Early notable gainers among liquid option names on January 10th 12/01/21 Early notable gainers among liquid option names on December 1st
Recommendations	Nio could be back to pre-shutdown levels by June, says Mizuho » 06:45 05/23/22 05/23 06:45 05/23/22 06:45 NIO Nio $16.44 / -0.23 (-1.38%) , TSLA Tesla $664.10 / -45.39 (-6.40%) Mizuho analyst Vijay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NIO TSLA NIO Nio $16.44 / -0.23 (-1.38%) 05/20/22 Nio up 7% in pre-market after company announced Singapore exchange listing 05/05/22 Nio provides update on HFCAA status 05/01/22 Nio delivers 5,074 vehicles in April 2022 04/11/22 Nio falls -10.3% TSLA Tesla $664.10 / -45.39 (-6.40%) 05/20/22 Elon Musk: We will never surrender/settle an unjust case against us 05/20/22 Musk denies he sexually harassed flight attendant on private jet 05/19/22 Tesla investor calls on company to buy back shares 05/18/22 Musk calls ESG 'outrageous scam' after S&P removes Tesla NIO TSLA NIO Nio $16.44 / -0.23 (-1.38%) 05/16/22 BofA Nio upgraded to Buy at BofA on 'brighter' second half view 05/16/22 BofA Nio upgraded to Buy from Neutral at BofA 05/02/22 Morgan Stanley Nio's April sales 'crimped' by lockdowns, says Morgan Stanley 04/13/22 Nomura Nio production halt limited to weekends, says Nomura TSLA Tesla $664.10 / -45.39 (-6.40%) 05/19/22 Wedbush Tesla price target lowered to $1,000 from $1,400 at Wedbush 05/18/22 Exane BNP Paribas Tesla gets price target cut after losing Exane's 'EV World Cup' 05/18/22 Piper Sandler Tesla price target lowered to $1,035 from $1,260 at Piper Sandler 05/17/22 Tudor Pickering Tesla upgraded to Hold from Sell at Tudor Pickering NIO TSLA NIO Nio $16.44 / -0.23 (-1.38%) 03/24/22 Nio sees Q1 revenue $1.51B-$1.57B, consensus $1.66B 03/24/22 Nio reports Q4 EPS (21c), consensus (21c) TSLA Tesla $664.10 / -45.39 (-6.40%) 04/20/22 Tesla reports Q1 EPS $3.22, consensus $2.26 04/20/22 Notable companies reporting after market close 01/26/22 Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26 01/26/22 Notable companies reporting after market close NIO TSLA NIO Nio $16.44 / -0.23 (-1.38%) 04/10/22 Nio suspends production due to supply chain disruptions, Reuters reports 04/05/22 Nio in discussions on licensing battery-swapping technology, FT reports 02/23/22 Nio plans to make own phones to interact with its cars, DigiTimes reports 02/10/22 Chinese local media say Nio planning mass-market sub-brand, CnEVPost reports TSLA Tesla $664.10 / -45.39 (-6.40%) 05/20/22 SpaceX paid $250,000 to settle harassment claim against Musk, Insider reports 05/19/22 Twitter execs say deal proceeding as planned, not 'on hold,' Bloomberg reports 05/19/22 Twitter execs say deal not 'on hold,' proceeding as planned, Bloomberg reports 05/18/22 NHTSA investigating fatal Tesla crash in California, Reuters says NIO TSLA NIO Nio $16.44 / -0.23 (-1.38%) 05/16/22 What You Missed This Week in EVs and Clean Energy 05/04/22 Here's what Wall Street experts are saying about these EV names ahead of results 05/02/22 What You Missed On Wall Street On Monday 05/02/22 What You Missed On Wall Street This Morning TSLA Tesla $664.10 / -45.39 (-6.40%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/19/22 What You Missed On Wall Street This Morning 05/19/22 Fly Intel: Pre-market Movers 06/09/22 Nio - NIO NIO TSLA NIO Nio $16.44 / -0.23 (-1.38%) 05/20/22 Unusually active option classes on open May 20th 05/09/22 Notable open interest changes for May 9th 04/04/22 NIO call volume above normal and directionally bullish 04/04/22 Notable open interest changes for April 4th TSLA Tesla $664.10 / -45.39 (-6.40%) 05/19/22 Notable open interest changes for May 19th 05/17/22 Notable open interest changes for May 17th 05/16/22 Notable open interest changes for May 16th 05/12/22 Unusually active option classes on open May 12th
Upgrade	Trimble upgraded to Equal Weight from Underweight at Morgan Stanley » 06:43 05/23/22 05/23 06:43 05/23/22 06:43 TRMB Trimble $65.24 / +0.16 (+0.25%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TRMB Trimble $65.24 / +0.16 (+0.25%) 04/20/22 Wabtec to acquire Trimble Beena Vision business, terms undisclosed 04/13/22 Trimble to divest four businesses to The Jordan Company, terms undisclosed 12/15/21 Trimble acquires AgileAssets, terms undisclosed 12/10/21 Trimble senior VP Kirkland sells 6,899 common shares TRMB Trimble $65.24 / +0.16 (+0.25%) 05/06/22 Baird Trimble price target lowered to $80 from $90 at Baird 03/28/22 JPMorgan Trimble price target lowered to $77 from $79 at JPMorgan 10/14/21 Piper Sandler Trimble initiated with Overweight on digitization at Piper Sandler 10/14/21 Piper Sandler Trimble initiated with an Overweight at Piper Sandler TRMB Trimble $65.24 / +0.16 (+0.25%) 05/05/22 Trimble cuts FY22 EPS view to $2.71-$2.86 from $2.75-$2.95, consensus $2.89 05/05/22 Trimble reports Q1 EPS 73c, consensus 67c 02/09/22 Trimble sees FY22 EPS $2.75-$2.95, consensus $2.96 02/09/22 Trimble reports Q4 EPS 62c, consensus 63c 05/25/22 Trimble Inc.
Initiation	Theravance Biopharma initiated with an Outperform at SVB Leerink » 06:43 05/23/22 05/23 06:43 05/23/22 06:43 TBPH Theravance Biopharma $8.74 / -0.09 (-1.02%) SVB Leerink analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TBPH Theravance Biopharma $8.74 / -0.09 (-1.02%) 04/04/22 Theravance Biopharma announces results from Study 0170 03/28/22 Protagonist Therapeutics names Asif Ali as CFO 03/01/22 Connect Biopharma appoints Chin Lee as CMO 02/23/22 Theravance Biopharma expects to be sustainably cash-flow positive beginning 2H22 TBPH Theravance Biopharma $8.74 / -0.09 (-1.02%) 02/24/22 H.C. Wainwright Theravance Biopharma price target raised to $12 from $8 at H.C. Wainwright 11/05/21 JPMorgan Theravance Biopharma upgraded to Neutral from Underweight at JPMorgan 09/16/21 Baird Theravance Biopharma price target lowered to $7 from $10 at Baird 09/16/21 H.C. Wainwright Theravance price target lowered to $8 from $21 at H.C. Wainwright TBPH Theravance Biopharma $8.74 / -0.09 (-1.02%) 05/05/22 Theravance Biopharma reports Q1 EPS (34c), consensus (11c) 02/23/22 Theravance Biopharma reports Q4 EPS (43c), consensus (33c) 25 Jun TBPH Theravance Biopharma $8.74 / -0.09 (-1.02%) 04/04/22 Fly Intel: After-Hours Movers
Initiation	Roivant Sciences initiated with an Outperform at SVB Leerink » 06:42 05/23/22 05/23 06:42 05/23/22 06:42 ROIV Roivant Sciences $3.72 / +0.075 (+2.06%) SVB Leerink analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ROIV Roivant Sciences $3.72 / +0.075 (+2.06%) 05/16/22 Aruvant announces oral presentation on ARU-1801 05/02/22 Roivant Sciences announces collaborations in targeted protein degradation 05/02/22 Roivant Sciences appoints Srini Ramanathan as CDO 04/20/22 VantAI forms research collaboration with Boehringer Ingelheim ROIV Roivant Sciences $3.72 / +0.075 (+2.06%) 04/29/22 Cantor Fitzgerald Roivant Sciences initiated with an Overweight at Cantor Fitzgerald 12/15/21 Goldman Sachs Roivant Sciences initiated with a Buy at Goldman Sachs 12/02/21 H.C. Wainwright H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant 11/08/21 H.C. Wainwright Roivant Sciences initiated with a Buy at H.C. Wainwright ROIV Roivant Sciences $3.72 / +0.075 (+2.06%) 02/14/22 Roivant Sciences reports Q4 EPS (41c), consensus (25c) ROIV Roivant Sciences $3.72 / +0.075 (+2.06%) 04/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/14/22 Fly Intel: Pre-market Movers 12/22/21 Fly Intel: After-Hours Movers ROIV Roivant Sciences $3.72 / +0.075 (+2.06%) 01/11/22 Nine new option listings on January 11th

Conference/Events	United Fire Group management to meet with Piper Sandler » 06:42 05/23/22 05/23 06:42 05/23/22 06:42 UFCS United Fire Group $29.42 / -1.13 (-3.70%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events UFCS United Fire Group $29.42 / -1.13 (-3.70%) 05/18/22 United Fire Group increases quarterly dividend 6.7% to 16c per share 03/22/22 United Fire Group appoints Eric Martin CFO 02/22/22 United Fire Group CEO Randy Ramlo to retire 02/10/22 United Fire Group general counsel Neal Scharmer to retire UFCS United Fire Group $29.42 / -1.13 (-3.70%) 03/21/22 Piper Sandler United Fire Group price target raised to $37 from $30 at Piper Sandler 12/01/21 Piper Sandler United Fire Group upgraded to Overweight from Neutral at Piper Sandler 07/09/21 Piper Sandler United Fire Group price target lowered to $28 from $35 at Piper Sandler 06/28/21 Sidoti United Fire Group upgraded to Buy from Neutral at Sidoti UFCS United Fire Group $29.42 / -1.13 (-3.70%) 05/05/22 United Fire Group reports Q1 adjusted EPS $1.13, consensus 84c 02/15/22 United Fire Group reports Q4 adjusted EPS $1.69, consensus 41c 05/24/22 United Fire Group 05/25/22 United Fire Group 05/26/22 United Fire Group
Upgrade	Zebra Technologies upgraded to Equal Weight from Underweight at Morgan Stanley » 06:41 05/23/22 05/23 06:41 05/23/22 06:41 ZBRA Zebra Technologies $325.57 / +0.995 (+0.31%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ZBRA Zebra Technologies $325.57 / +0.995 (+0.31%) 05/17/22 Zebra Technologies announces additional $1B share repurchase program 03/15/22 Zebra to acquire machine vision company Matrox Imaging for $875M 12/22/21 Optoro receives strategic investment led by Zebra Technologies 12/14/21 Zebra Technologies director Modruson sells 2,000 class A shares ZBRA Zebra Technologies $325.57 / +0.995 (+0.31%) 05/04/22 Needham Zebra Technologies price target lowered to $500 from $535 at Needham 05/04/22 Baird Zebra Technologies price target lowered to $440 from $550 at Baird 04/12/22 Morgan Stanley Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious 04/12/22 Morgan Stanley Zebra Technologies price target lowered to $400 from $470 at Morgan Stanley ZBRA Zebra Technologies $325.57 / +0.995 (+0.31%) 05/03/22 Zebra Technologies sees FY22 revenue growth of 3%-7%, consensus $5.95B 05/03/22 Zebra Technologies sees Q2 adjusted EPS $4.05 -$4.35, consensus $4.52 05/03/22 Zebra Technologies reports Q1 adjusted EPS $4.01, consensus $3.87 02/10/22 Zebra Technologies sees FY22 revenue growth of 3%-7%, consensus $5.92B ZBRA Zebra Technologies $325.57 / +0.995 (+0.31%) 04/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today 50th Annual Global Technology, Media & Communications Conference 09/12/22 Zebra Technologies - ZBRA ZBRA Zebra Technologies $325.57 / +0.995 (+0.31%) 04/04/22 Early notable gainers among liquid option names on April 4th
Initiation	Alteryx initiated with an Outperform at FBN Securities » 06:41 05/23/22 05/23 06:41 05/23/22 06:41 AYX Alteryx $55.68 / +0.16 (+0.29%) FBN Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AYX Alteryx $55.68 / +0.16 (+0.29%) 04/05/22 Alteryx names Lucas Moody as Chief Information Security Officer 03/25/22 Alteryx announces strategic investment in Vertis 02/16/22 Alteryx rises 12.4% 02/16/22 Alteryx rises 8.7% AYX Alteryx $55.68 / +0.16 (+0.29%) 05/04/22 Loop Capital Alteryx price target raised to $67 from $60 at Loop Capital 05/04/22 Cowen Alteryx price target raised to $90 from $75 at Cowen 05/04/22 Citi Alteryx price target raised to $95 from $86 at Citi 04/01/22 Needham Alteryx price target raised to $86 from $66 at Needham AYX Alteryx $55.68 / +0.16 (+0.29%) 05/03/22 Alteryx sees FY22 non-GAAP EPS (56c)-(46c), consensus (64c) 05/03/22 Alteryx sees Q2 non-GAAP EPS (61c)-(58c), consensus (29c) 05/03/22 Alteryx reports Q1 non-GAAP EPS (40c), consensus (59c) 02/15/22 Alteryx sees FY22 adjusted EPS (68c)-(58c), consensus (8c) AYX Alteryx $55.68 / +0.16 (+0.29%) 02/16/22 What You Missed On Wall Street On Wednesday 02/16/22 What You Missed On Wall Street This Morning 02/15/22 Fly Intel: After-Hours Movers 02/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today 50th Annual Global Technology, Media & Communications Conference 06/01/22 50th Annual Technology, Media & Telecom Conference 06/07/22 Global Technology Conference 2022 05/25/22 Alteryx, Inc. AYX Alteryx $55.68 / +0.16 (+0.29%) 02/15/22 Alteryx options imply 14.2% move in share price post-earnings
Recommendations	April delinquency trends promising for Affirm, says Mizuho » 06:41 05/23/22 05/23 06:41 05/23/22 06:41 AFRM Affirm / + Mizuho analyst Dan Dolev… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AFRM Affirm / + 05/12/22 Affirm CEO: Our underlying business is performing very well 05/12/22 Affirm jumps 22% to $21.97 after Q3 results beat, FY22 guidance raised 05/12/22 Affirm extends multi-year partnership with Shopify in U.S. 05/04/22 Affirm to be first BNPL partner fully integrated to Carat from Fiserv AFRM Affirm / + 05/17/22 Mizuho Affirm price target lowered to $50 from $79 at Mizuho 05/16/22 Barclays Affirm price target lowered to $35 from $65 at Barclays 05/13/22 RBC Capital Affirm price target lowered to $48 from $58 at RBC Capital 05/13/22 Morgan Stanley Affirm results reassuring, investors likely still cautious, says Morgan Stanley AFRM Affirm / + 05/12/22 Affirm raises FY22 revenue view to $1.33B-$1.34B from at least $1.31B 05/12/22 Affirm sees Q4 revenue $345M-$355M, consensus $351.88M 05/12/22 Affirm reports Q3 EPS (19c), consensus (54c) 05/12/22 Notable companies reporting after market close AFRM Affirm / + 05/19/22 Klarna looks to raise up to $1B at lower valuation, WSJ reports 03/14/22 Affirm halts bond sale because of market volatility, Bloomberg reports 12/16/21 CFPB to seek buy now, pay later information from Affirm, others, Bloomberg says AFRM Affirm / + 05/13/22 What You Missed On Wall Street On Friday 05/13/22 What You Missed On Wall Street This Morning 05/13/22 Fly Intel: Pre-market Movers 05/12/22 Fly Intel: After-Hours Movers 00:00 Today 50th Annual Global Technology, Media & Communications Conference AFRM Affirm / + 05/13/22 Notable open interest changes for May 13th 05/12/22 Affirm Holdings options imply 29.7% move in share price post-earnings 04/25/22 Affirm Holdings call volume above normal and directionally bullish 04/22/22 Affirm Holdings call volume above normal and directionally bullish
Downgrade	Frontdoor downgraded to Hold from Buy at Truist » 06:41 05/23/22 05/23 06:41 05/23/22 06:41 FTDR Frontdoor $26.45 / +0.245 (+0.94%) Truist analyst Youssef… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FTDR Frontdoor $26.45 / +0.245 (+0.94%) 05/20/22 Frontdoor CEO Rexford Tibbens to step down, chairman William Cobb to succeed FTDR Frontdoor $26.45 / +0.245 (+0.94%) 05/06/22 Truist Frontdoor price target lowered to $32 from $50 at Truist 05/06/22 Raymond James Frontdoor price target lowered to $31 from $40 at Raymond James 05/06/22 Oppenheimer Frontdoor price target lowered to $34 from $41 at Oppenheimer 01/06/22 Goldman Sachs Frontdoor assumed with a Neutral at Goldman Sachs FTDR Frontdoor $26.45 / +0.245 (+0.94%) 05/05/22 Frontdoor cuts FY22 revenue view $1.66B-$1.69B from $1.7B-$1.73B 05/05/22 Frontdoor sees Q2 revenue $475M-$485M, consensus $489.16M 05/05/22 Frontdoor reports Q1 adjusted EPS 4c, consensus 9c 02/24/22 Frontdoor sees FY22 revenue $1.70B-$1.73B, consensus $1.72B

Conference/Events	Timken management to meet with Loop Capital » 06:40 05/23/22 05/23 06:40 05/23/22 06:40 TKR Timken $57.88 / -0.735 (-1.25%) Meetings to be held in CA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TKR Timken $57.88 / -0.735 (-1.25%) 05/02/22 Timken reports Q1 adjusted EPS $1.61, consensus $1.16 04/29/22 Timken to acquire Spinea, terms undisclosed 02/15/22 Timken wins contract as provider of high-precision drives for solar power plant TKR Timken $57.88 / -0.735 (-1.25%) 05/03/22 KeyBanc Timken price target lowered to $75 from $84 at KeyBanc 04/13/22 Oppenheimer Timken initiated with an Outperform at Oppenheimer 02/15/22 Evercore ISI Timken upgraded to Outperform at Evercore ISI on relative valuation 02/15/22 Evercore ISI Oshkosh downgraded to In Line at Evercore ISI on relative valuation TKR Timken $57.88 / -0.735 (-1.25%) 05/02/22 Timken backs FY22 adjusted EPS $5.00-$5.40, consensus $5.23 02/03/22 Timken sees FY22 adjusted EPS $5.00-$5.40, consensus $5.71 02/03/22 Timken reports Q4 adjusted EPS 78c, consensus 91c 05/24/22 Timken 05/25/22 Timken
Upgrade	TreeHouse upgraded to Buy from Hold at Truist » 06:40 05/23/22 05/23 06:40 05/23/22 06:40 THS TreeHouse / + Truist analyst Bill… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events THS TreeHouse / + 05/16/22 Jana Partners exits Macy's, cuts LabCorp in Q1 05/09/22 TreeHouse rises 17.0% 04/12/22 TreeHouse appoints Scott Ostfeld of JANA Partners to board 03/14/22 TreeHouse provides update on strategic review of alternatives THS TreeHouse / + 03/22/22 Truist TreeHouse price target lowered to $35 from $40 at Truist THS TreeHouse / + 05/09/22 TreeHouse sees 2022 net sales growth of at least 11% y-o-y, consensus $4.75B 05/09/22 TreeHouse reports Q1 adjusted EPS (15c), consensus (52c) 03/14/22 TreeHouse backs FY22 revenue view up 11%, consensus $4.76B 02/14/22 TreeHouse sees FY22 revenue up 11%, consensus $4.43B THS TreeHouse / + 02/14/22 What You Missed On Wall Street On Monday 02/14/22 What You Missed On Wall Street This Morning 05/26/22 TreeHouse Foods, Inc.
Initiation	Upwork initiated with a Sector Perform at RBC Capital » 06:40 05/23/22 05/23 06:40 05/23/22 06:40 UPWK Upwork $18.32 / +0.24 (+1.33%) , MSFT Microsoft $252.57 / -0.44 (-0.17%) RBC Capital analyst Brad… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UPWK MSFT UPWK Upwork $18.32 / +0.24 (+1.33%) 03/07/22 Upwork says a number of staff in Russia/Belarus region have already moved 03/07/22 Upwork CEO says suspending business in Russia 'a very difficult decision' 03/07/22 Upwork announces suspension of business in Russia, Belarus 01/06/22 Upwork announces Melissa Waters joins as chief marketing officer MSFT Microsoft $252.57 / -0.44 (-0.17%) 05/19/22 CD Projekt says next-gen 'Witcher 3' version to release in 4Q22 05/19/22 National Research Corporation appoints Parul Bhandari to board 05/19/22 Itron expands collaboration with Microsoft on cloud solutions for energy 05/18/22 American Airlines to use Microsoft Azure as its preferred cloud platform UPWK MSFT UPWK Upwork $18.32 / +0.24 (+1.33%) 05/17/22 Piper Sandler 'Interesting time' to be looking at Upwork story, says Piper Sandler 05/16/22 Stifel Upwork downgraded to Hold from Buy at Stifel 04/28/22 Needham Upwork price target lowered to $33 from $42 at Needham 04/28/22 Canaccord Upwork price target lowered to $36 from $40 at Canaccord MSFT Microsoft $252.57 / -0.44 (-0.17%) 05/19/22 RBC Capital Microsoft investor meetings indicate no change to macro/demand, says RBC Capital 05/13/22 Tigress Financial Microsoft pullback 'major buying opportunity,' says Tigress Financial 05/06/22 Benchmark Playstudios could still be target as industry consolidates, says Benchmark 04/29/22 OTR Global Okta view downgraded to Negative from Mixed at OTR Global UPWK MSFT UPWK Upwork $18.32 / +0.24 (+1.33%) 04/27/22 Upwork sees FY22 revenue $590M-$610M, consensus $599.52M 04/27/22 Upwork sees Q2 EPS (10c)-(6c), consensus (8c) 04/27/22 Upwork reports Q1 EPS (19c), consensus (14c) 03/07/22 Upwork withdraws Q1, 2022 guidance due to uncertainties amid Russian invasion MSFT Microsoft $252.57 / -0.44 (-0.17%) 04/26/22 Microsoft sees Q4 productivity and business processes revenue $16.65B-$16.9B 04/26/22 Microsoft reports Q3 EPS $2.22 consensus $2.18 04/26/22 Notable companies reporting after market close 01/25/22 Microsoft reports Q2 EPS $2.48, consensus $2.31 MSFT MSFT Microsoft $252.57 / -0.44 (-0.17%) 06:34 Today Electronic Arts reportedly looking to sell or merge, Kotaku reports 05/19/22 Microsoft president says Activision Blizzard deal proceeding quickly, VGC says 05/19/22 Xbox Series S outsold PlayStation 5 in Japan last week, Famitsu reports 05/18/22 Parent sues Blizzard over non-refundable 'Hearthstone' cards, Polygon reports UPWK MSFT UPWK Upwork $18.32 / +0.24 (+1.33%) 04/27/22 Fly Intel: After-Hours Movers 03/07/22 What You Missed On Wall Street On Monday 03/07/22 What You Missed On Wall Street This Morning 02/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MSFT Microsoft $252.57 / -0.44 (-0.17%) 05/19/22 What You Missed On Wall Street On Thursday 05/17/22 What You Missed This Week in Video Games 05/12/22 What You Missed On Wall Street This Morning 05/10/22 What You Missed This Week in Video Games 00:00 Today 50th Annual Global Technology, Media & Communications Conference 06/14/22 Microsoft - MSFT 06/02/22 Upwork Inc. 06/06/22 Microsoft UPWK MSFT UPWK Upwork $18.32 / +0.24 (+1.33%) 02/10/22 Upwork options imply 12.7% move in share price post-earnings MSFT Microsoft $252.57 / -0.44 (-0.17%) 05/02/22 Microsoft put buyer realizes 57% same-day gains 04/27/22 Early notable gainers among liquid option names on April 27th 04/27/22 Notable open interest changes for April 27th 04/26/22 Microsoft call buyer realizes 19% same-day gains
Initiation	Radius Health initiated with a Market Perform at SVB Leerink » 06:40 05/23/22 05/23 06:40 05/23/22 06:40 RDUS Radius Health $6.25 / +0.41 (+7.03%) , AMGN Amgen $247.42 / +2.48 (+1.01%) SVB Leerink analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options RDUS AMGN RDUS Radius Health $6.25 / +0.41 (+7.03%) 05/20/22 Radius Health appoints Jennifer Jarrett, Susan Vissers Lisa to board 05/20/22 Radius Health, Menarini announce data from EMERALD trial published 05/19/22 Radius Health announces publication of elacestrant clinical trial data 03/16/22 Radius Health appoints Conley as CFO, Clarke as General Counsel AMGN Amgen $247.42 / +2.48 (+1.01%) 05/16/22 Crispr Therapeutics appoints Morrow as CMO 05/04/22 BeiGene granted conditional approval of Blincyto by China NMPA 04/27/22 Amgen receives notice of deficiency from IRS for 2013-2015 period 04/27/22 Amgen's reports safety and efficacy results of Repatha Phase 3 studies RDUS AMGN RDUS Radius Health $6.25 / +0.41 (+7.03%) 12/23/21 Stifel New Radius' Tymlos label offers slight expansion potential, says Stifel 12/10/21 Morgan Stanley Radius Health downgraded to Underweight from Equal Weight at Morgan Stanley 12/09/21 Goldman Sachs Radius Health downgraded to Neutral from Buy at Goldman Sachs 12/09/21 H.C. Wainwright Radius Health price target lowered to $10 from $23 at H.C. Wainwright AMGN Amgen $247.42 / +2.48 (+1.01%) 06:20 Today SVB Leerink Amgen initiated with a Market Perform at SVB Leerink 05/10/22 Mizuho Amgen price target raised to $208 from $202 at Mizuho 05/05/22 Stifel ASCO sets up as 'downside-biased' for Mirati investors, says Stifel 04/28/22 BMO Capital Amgen price target lowered to $243 from $263 at BMO Capital RDUS AMGN RDUS Radius Health $6.25 / +0.41 (+7.03%) 05/05/22 Radius Health sees 2022 TYMLOS net revenue $232M 05/05/22 Radius Health reports Q1 EPS (39c), consensus (21c) 02/24/22 Radius Health reports Q4 adjusted EPS (5c), consensus (18c) 02/24/22 Radius Health sees 2022 Tymlos revenue of $232M AMGN Amgen $247.42 / +2.48 (+1.01%) 04/27/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.63 04/27/22 Amgen reports Q1 adjusted EPS $4.25, consensus $4.10 04/27/22 Notable companies reporting after market close 02/08/22 Amgen sees FY22 revenue $25.4B-$26.5B, consensus $27B AMGN AMGN Amgen $247.42 / +2.48 (+1.01%) 03/07/22 Johnson & Johnson negotiating deals with two Chinese companies, FT reports 12/14/21 Moderna, Amgen among biotech companies pulling out of JPM conference, STAT says RDUS AMGN RDUS Radius Health $6.25 / +0.41 (+7.03%) 05/19/22 Fly Intel: After-Hours Movers 12/08/21 Wall Street in Fives - Must Read Lists for Wednesday 12/08/21 Wall Street in Fives - Must Read Lists at Midday AMGN Amgen $247.42 / +2.48 (+1.01%) 04/28/22 What You Missed On Wall Street On Thursday 04/27/22 Fly Intel: After-Hours Movers 02/08/22 Wall Street in Fives - Must Read Lists for Tuesday 02/08/22 Wall Street in Fives - Must Read Lists at Midday 06/03/22 2022 ASCO Annual Meeting 06/21/22 Amgen RDUS AMGN RDUS Radius Health $6.25 / +0.41 (+7.03%) 01/07/22 Unusually active option classes on open January 7th AMGN Amgen $247.42 / +2.48 (+1.01%) 02/08/22 Early notable gainers among liquid option names on February 8th 01/03/22 Amgen call volume above normal and directionally bullish
Hot Stocks	American Vanguard issues stockholder letter in support of director nominees » 06:38 05/23/22 05/23 06:38 05/23/22 06:38 AVD American Vanguard $22.31 / -0.52 (-2.28%) American Vanguard sent a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events AVD American Vanguard $22.31 / -0.52 (-2.28%) 05/19/22 Glass Lewis urges American Vanguard investors to vote for Cruiser nominees 05/19/22 Cruiser Capital urges American Vanguard shareholders to vote for nominees 05/13/22 Cruiser Capital urges American Vanguard shareholders to vote for nominees 05/11/22 Cruiser Capital urges American Vanguard shareholders to vote for nominees 06/01/22 American Vanguard Corp

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

XPeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
CSTE
Today at 08:00

Caesarstone Firm Sponsored Meetings

Virtual Meeting
JPM
Today at 08:00

JPMorgan Firm Sponsored Meetings

Virtual Meeting
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: April 2022 Government Event
Today at 08:30

Chicago Fed National Activity Index: April 2022 Government Event
RSLS
Today at 08:30

ReShape Lifesciences - RSLS Conference Calls
AVPT
Today at 09:00

AvePoint Firm Sponsored Meetings

Virtual Meeting
GILT
Today at 09:30

Gilat Satellite - GILT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Goldman Sachs alternative energy analysts hold analyst/industry conference call

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access